Yun Kang

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

China National Pharmaceutical Group Corporation (China)(Current)

Chinese Center For Disease Control and Prevention

Khalifa University of Science and Technology

National Institute for Viral Disease Control and Prevention

Shaikh Khalifa Medical City

Yun Kang is an author at China National Pharmaceutical Group Corporation (China) specializing in booster immunization, vaccinology, and vaccine immunology.

Publications per year

2015–2022

Publications

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Nawal Al Kaabi, Yun Yang, Li Fang Du et al. · Nature Communications · 2022 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

Nawal Al Kaabi, Yun Yang, Jing Zhang et al. · Signal Transduction and Targeted Therapy · 2022 · 31 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The effect of Piper laetispicum extract (EAE-P) during chronic unpredictable mild stress based on interrelationship of inflammatory cytokines, apoptosis cytokines and neurotrophin in the hippocampus

Hui Xie, Di Jin, Yun Kang et al. · BMC Complementary and Alternative Medicine · 2015 · 15 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–3 of 3